In this section we usually present revenue and earnings growth
projections based on the consensus estimates of professional
analysts to help investors understand the company’s ability to
generate profit. But as Bioray Biotech has not provided enough
past data and has no analyst forecast, its future earnings
cannot be reliably calculated by extrapolating past data or
using analyst predictions.
This is quite a rare situation as 97% of companies covered by
SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
TPEX:7561 - Analysts future estimates and past financials data (TWD Millions)
Date
Revenue
Earnings
Free Cash Flow
Cash from Op
Avg. No. Analysts
12/31/2025
223
32
71
72
N/A
9/30/2025
226
31
51
53
N/A
6/30/2025
230
31
31
34
N/A
3/31/2025
216
16
22
25
N/A
12/31/2024
202
1
13
17
N/A
9/30/2024
193
-7
8
12
N/A
6/30/2024
184
-16
4
6
N/A
3/31/2024
188
-14
-4
3
N/A
12/31/2023
192
-12
-11
-1
N/A
9/30/2023
194
-9
-11
2
N/A
6/30/2023
196
-6
-11
5
N/A
3/31/2023
193
-3
-35
4
N/A
12/31/2022
191
1
-58
2
N/A
9/30/2022
182
0
-53
6
N/A
6/30/2022
174
0
-48
10
N/A
3/31/2022
161
-3
-27
9
N/A
12/31/2021
148
-7
-7
9
N/A
9/30/2021
141
-9
-4
15
N/A
6/30/2021
133
-11
-2
21
N/A
3/31/2021
145
-6
-26
12
N/A
12/31/2020
156
0
-50
2
N/A
9/30/2020
169
7
-71
-7
N/A
6/30/2020
183
14
-92
-15
N/A
3/31/2020
182
17
-46
24
N/A
12/31/2019
182
19
-1
62
N/A
9/30/2019
189
25
N/A
70
N/A
6/30/2019
197
31
N/A
78
N/A
3/31/2019
191
26
N/A
49
N/A
12/31/2018
185
22
N/A
21
N/A
12/31/2017
124
3
N/A
9
N/A
12/31/2016
108
15
N/A
34
N/A
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if 7561's forecast earnings growth is above the savings rate (1.3%).
Earnings vs Market: Insufficient data to determine if 7561's earnings are forecast to grow faster than the TW market
High Growth Earnings: Insufficient data to determine if 7561's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if 7561's revenue is forecast to grow faster than the TW market.
High Growth Revenue: Insufficient data to determine if 7561's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 7561's Return on Equity is forecast to be high in 3 years time
Discover growth companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/10 15:19
End of Day Share Price
2026/06/10 00:00
Earnings
2025/12/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bioray Biotech Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.